Cancer Treatment Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

Cancer Treatment Stocks Recent News

Date Stock Title
Sep 26 IOVA 3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow
Sep 25 TCBP TCBP Announces Site Opening of Guys and St. Thomas Hospital
Sep 25 GDTC Presenting on the Emerging Growth Conference 75 Day 2 on September 26
Sep 25 ADAP Adaptimmune Therapeutics plc's (NASDAQ:ADAP) top owners are individual investors with 39% stake, while 28% is held by institutions
Sep 24 TCBP TCBP to Present at the 2024 ThinkEquity Conference in NYC
Sep 23 IPHA Innate gets FDA clearance for Phase 1 study for IPH4502 ADC candidate
Sep 23 STRO Sutro Biopharma's Competitive ADCs Position It For Future Growth In Oncology
Sep 23 BDTX Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug
Sep 23 BDTX Black Diamond reports encouraging Phase 2 data for BDTX-1535
Sep 23 BDTX Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations
Sep 23 IPHA FDA grants IND clearance for Innate Pharma’s solid tumour trial
Sep 23 IPHA Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors
Sep 22 BDTX Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC
Sep 21 IBRX ImmunityBio: Anktiva Launch, Good Data, Low Cash, High Debt
Cancer Treatment

Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

Browse All Tags